GT Biopharma(GTBP)
$3.72-0.12 (-3.13%)
GTBP
GT Biopharma financials statements
$3.72
At close:-0.12 (-3.13%)
Want to see GTBP full AI Analyst Report?
GT Biopharma (GTBP) Income Statement
369 Followers
GT Biopharma Income Statement
Last quarter (Q2 2026), GT Biopharma's total revenue was $0.00. In Q2, GT Biopharma's net income was $-4.52M. See GT Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 12.42M | $ 14.36M | $ 13.58M | $ 21.26M | $ 57.52M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 13.58M | $ 0.00 | $ 0.00 |
| $ -28.23M | $ -13.16M | $ 5.98M | $ -20.96M | $ -57.48M | |
| $ -12.42M | $ -14.36M | $ -13.58M | $ -21.26M | $ -57.52M | |
| $ -15.93M | $ 1.20M | $ 5.98M | $ 373.00K | $ -498.00K | |
| $ -28.35M | $ -13.16M | $ -7.60M | $ -20.88M | $ -58.01M | |
| $ -28.35M | $ -13.16M | $ -7.60M | $ -20.88M | $ -58.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ -156.25 | $ -173.50 | $ -141.00 | $ -16.50 | $ -51.50 |
| Diluted EPS | $ -156.25 | $ -173.50 | $ -141.00 | $ -16.50 | $ -51.50 |
| Weighted Average Shares Outstanding | 220.53K | 75.88K | 53.88K | 1.27M | 1.13M |
| Weighted Average Shares Outstanding (Diluted) | 220.53K | 75.88K | 53.92K | 1.27M | 1.13M |
Currency in USD
